UiPath Inc.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Jan 31, 2026 · FY), UiPath Inc. reported revenue of $1.6B (+12.7% year on year) and net income of $282.3M (+483.1% year on year).
| Line item | Jan 31, 2026 · FY | Jan 31, 2025 · FY | Jan 31, 2024 · FY | Jan 31, 2023 · FY |
|---|---|---|---|---|
| Total revenue | $1.6B | $1.4B | $1.3B | $1.1B |
| Total cost of revenue | $271.0M | $246.9M | $195.9M | $180.1M |
| Gross profit | $1.3B | $1.2B | $1.1B | $878.5M |
| Sales and marketing | $683.3M | $738.5M | $713.1M | $701.6M |
| Research and development | $385.2M | $380.7M | $332.1M | $285.8M |
| General and administrative | $214.3M | $226.1M | $231.6M | $239.5M |
| Total operating expenses | $1.3B | $1.3B | $1.3B | $1.2B |
| Operating income (loss) | $56.8M | ($162.6M) | ($164.7M) | ($348.3M) |
| Interest income | $48.0M | $49.4M | $57.1M | $28.0M |
| Other (expense) income, net | ($4.2M) | $35.0M | $31.8M | $2.8M |
| Income (loss) before income taxes | $100.6M | ($78.1M) | ($75.8M) | ($317.6M) |
| (Benefit from) provision for income taxes | ($181.7M) | ($4.4M) | $14.1M | $10.8M |
| Net income (loss) | $282.3M | ($73.7M) | ($89.9M) | ($328.4M) |
| Net income (loss) per share, basic (in dollars per share) | $0.52 | -$0.13 | -$0.16 | -$0.60 |
| Net income (loss) per share, diluted (in dollars per share) | $0.52 | -$0.13 | -$0.16 | -$0.60 |
| Weighted-average shares used in computing net income (loss) per share, basic (in shares) | $538125000.00 | $559933000.00 | $563855000.00 | $548022000.00 |
| Weighted-average shares used in computing net income (loss) per share, diluted (in shares) | $544860000.00 | $559933000.00 | $563855000.00 | $548022000.00 |
| Line item | Jul 31, 2026 · Q2 | Apr 30, 2026 · Q1 | Oct 31, 2025 · Q3 | Jul 31, 2025 · Q2 |
|---|---|---|---|---|
| Total revenue | $410.3M | $418.4M | $411.1M | $361.7M |
| Total cost of revenue | $80.6M | $76.9M | $68.8M | $64.4M |
| Gross profit | $329.7M | $341.5M | $342.3M | $297.3M |
| Sales and marketing | $164.6M | $167.9M | $179.2M | $166.3M |
| Research and development | $83.4M | $92.9M | $96.9M | $98.3M |
| General and administrative | $50.1M | $52.7M | $53.2M | $52.9M |
| Total operating expenses | $298.1M | $313.5M | $329.2M | $317.5M |
| Operating income (loss) | $31.6M | $28.0M | $13.1M | ($20.2M) |
| Interest income | $10.8M | $10.4M | $11.7M | $12.0M |
| Other income (expense), net | $10.5M | $2.6M | ($180.0K) | $11.5M |
| Income (loss) before income taxes | $52.9M | $41.0M | $24.6M | $3.3M |
| Provision for income taxes | $16.8M | $18.4M | ($174.2M) | $1.7M |
| Net income (loss) | $36.1M | $22.5M | $198.8M | $1.6M |
| Net income (loss) per share, basic (in dollars per share) | $0.07 | $0.04 | $0.37 | $0.00 |
| Net income (loss) per share, diluted (in dollars per share) | $0.07 | $0.04 | $0.37 | $0.00 |
| Weighted-average shares used in computing net income (loss) per share, basic (in shares) | $519654000.00 | $523584000.00 | $532255000.00 | $536169000.00 |
| Weighted-average shares used in computing net income (loss) per share, diluted (in shares) | $523013000.00 | $527818000.00 | $539018000.00 | $542865000.00 |
| Line item | Jan 31, 2026 · FY | Jan 31, 2025 · FY | Jan 31, 2024 · FY | Jan 31, 2023 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $871.2M | $879.2M | $1.1B | $1.4B |
| Restricted cash | $438.0K | $438.0K | $438.0K | — |
| Marketable securities | $601.3M | $750.3M | $818.1M | $354.8M |
| Accounts receivable, net of allowance for credit losses of $5,222 and $1,642, respectively | $488.3M | $451.1M | $436.3M | $374.2M |
| Contract assets | $92.4M | $88.7M | $84.2M | $69.3M |
| Deferred contract acquisition costs | $84.7M | $82.5M | $74.7M | $49.9M |
| Prepaid expenses and other current assets | $105.6M | $86.3M | $105.0M | $94.2M |
| Total current assets | $2.2B | $2.3B | $2.6B | $2.3B |
| Marketable securities, non-current | $217.0M | $94.1M | $0 | $2.9M |
| Contract assets, non-current | $1.9M | $3.4M | $6.2M | $6.5M |
| Deferred contract acquisition costs, non-current | $153.7M | $139.3M | $154.3M | $137.6M |
| Property and equipment, net | $46.0M | $32.7M | $24.0M | $29.0M |
| Operating lease right-of-use assets | $64.5M | $66.5M | $56.1M | $52.1M |
| Intangible assets, net | $20.0M | $7.9M | $14.7M | $23.0M |
| Goodwill | $125.3M | $87.3M | $89.0M | $88.0M |
| Deferred tax assets | $233.4M | $28.0M | $4.7M | $5.9M |
| Other assets, non-current | $73.4M | $67.4M | $25.4M | $45.7M |
| Total assets | $3.2B | $2.9B | $3.0B | $2.7B |
| Accounts payable | $10.2M | $33.2M | $3.4M | $8.9M |
| Accrued expenses and other current liabilities | $170.5M | $83.9M | $84.0M | $76.6M |
| Accrued compensation and employee benefits | $121.0M | $112.4M | $137.4M | $142.6M |
| Deferred revenue | $603.7M | $569.5M | $486.8M | $398.3M |
| Total current liabilities | $905.4M | $798.9M | $711.7M | $626.5M |
| Deferred revenue, non-current | $103.6M | $135.8M | $161.0M | $121.7M |
| Operating lease liabilities, non-current | $70.9M | $74.2M | $58.7M | $56.4M |
| Other liabilities, non-current | $16.7M | $10.5M | $7.2M | $10.5M |
| Total liabilities | $1.1B | $1.0B | $938.6M | $815.0M |
| Preferred stock, $0.00001 par value per share, 20,000 shares authorized; none issued and outstanding | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock | $6.0K | $6.0K | $6.0K | $6.0K |
| Treasury stock, at cost, 68,552 and 37,621 shares, respectively | -833.9M | -494.8M | -102.6M | — |
| Additional paid-in capital | $4.6B | $4.3B | $4.0B | $3.7B |
| Accumulated other comprehensive income (loss) | $36.6M | ($4.9M) | $8.8M | $7.6M |
| Accumulated deficit | ($1.7B) | ($2.0B) | ($1.9B) | ($1.8B) |
| Total stockholders’ equity | $2.1B | $1.8B | $2.0B | $1.9B |
| Total liabilities and stockholders’ equity | $3.2B | $2.9B | $3.0B | $2.7B |
| Line item | Jul 31, 2026 | Apr 30, 2026 | Oct 31, 2025 | Jul 31, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $607.4M | $632.2M | $743.7M | $628.6M |
| Restricted cash | $1.5M | $1.5M | $438.0K | $438.0K |
| Marketable securities | $676.6M | $675.0M | $654.5M | $818.9M |
| Accounts receivable, net of allowance for credit losses of $6,400 and $5,222, respectively | $307.1M | $300.0M | $366.8M | $269.8M |
| Contract assets | $135.2M | $110.2M | $129.3M | $117.4M |
| Deferred contract acquisition costs | $86.5M | $86.6M | $86.5M | $85.2M |
| Prepaid expenses and other current assets | $112.3M | $112.8M | $112.1M | $110.4M |
| Total current assets | $1.9B | $1.9B | $2.1B | $2.0B |
| Marketable securities, non-current | $121.0M | $108.5M | $121.6M | $75.2M |
| Contract assets, non-current | $4.8M | $2.9M | $4.7M | $2.7M |
| Deferred contract acquisition costs, non-current | $165.0M | $155.2M | $137.8M | $136.0M |
| Property and equipment, net | $46.4M | $45.6M | $44.6M | $41.5M |
| Operating lease right-of-use assets | $63.5M | $66.4M | $65.2M | $65.6M |
| Intangible assets, net | $101.5M | $100.1M | $21.6M | $21.6M |
| Goodwill | $179.5M | $185.7M | $120.6M | $120.8M |
| Deferred tax assets | $230.1M | $249.5M | $213.0M | $26.0M |
| Other assets, non-current | $68.9M | $72.3M | $73.6M | $72.2M |
| Total assets | $2.9B | $2.9B | $2.9B | $2.6B |
| Accounts payable | $16.8M | $19.7M | $14.3M | $19.7M |
| Accrued expenses and other current liabilities | $156.9M | $178.7M | $151.9M | $145.9M |
| Accrued compensation and employee benefits | $89.9M | $61.2M | $88.6M | $65.9M |
| Deferred revenue | $543.6M | $572.1M | $534.0M | $506.9M |
| Total current liabilities | $807.3M | $831.7M | $788.7M | $738.4M |
| Deferred revenue, non-current | $71.7M | $86.2M | $99.2M | $104.3M |
| Operating lease liabilities, non-current | $69.4M | $72.0M | $72.0M | $72.6M |
| Other liabilities, non-current | $10.4M | $11.9M | $11.5M | $11.3M |
| Total liabilities | $958.8M | $1.0B | $971.4M | $926.6M |
| Preferred stock, $0.00001 par value per share, 20,000 shares authorized; none issued and outstanding | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock | $6.0K | $6.0K | $6.0K | $6.0K |
| Treasury stock, at cost, 91,351 and 68,552 shares, respectively | -1.1B | -1.1B | -824.3M | -824.8M |
| Additional paid-in capital | $4.7B | $4.6B | $4.5B | $4.5B |
| Accumulated other comprehensive income | $14.7M | $27.4M | $27.7M | $24.7M |
| Accumulated deficit | ($1.6B) | ($1.7B) | ($1.8B) | ($2.0B) |
| Total stockholders’ equity | $1.9B | $1.9B | $1.9B | $1.7B |
| Total liabilities and stockholders’ equity | $2.9B | $2.9B | $2.9B | $2.6B |
| Line item | Jan 31, 2026 · FY | Jan 31, 2025 · FY | Jan 31, 2024 · FY | Jan 31, 2023 · FY |
|---|---|---|---|---|
| Net income (loss) | $282.3M | ($73.7M) | ($89.9M) | ($328.4M) |
| Depreciation and amortization | $17.0M | $17.2M | $22.6M | $18.7M |
| Amortization of deferred contract acquisition costs | $109.4M | $92.1M | $75.5M | $59.8M |
| Net accretion on marketable securities | ($10.2M) | ($31.8M) | ($28.2M) | ($1.8M) |
| Stock-based compensation expense | $290.7M | $358.2M | $372.0M | $369.8M |
| Charitable donation of Class A common stock | $4.2M | $6.6M | $4.2M | $5.5M |
| Non-cash operating lease expense | $17.0M | $15.9M | $13.0M | $11.7M |
| (Benefit from) provision for deferred income taxes | ($202.7M) | ($19.8M) | $554.0K | $861.0K |
| Credit loss expense (benefit) | $5.7M | — | — | — |
| Other non-cash charges (credits), net | $7.1M | ($2.3M) | ($3.7M) | ($2.5M) |
| Accounts receivable | ($25.8M) | ($22.2M) | ($64.2M) | ($123.8M) |
| Contract assets | $3.2M | ($4.0M) | ($14.7M) | ($185.0K) |
| Deferred contract acquisition costs | ($116.2M) | ($89.2M) | ($118.8M) | ($118.9M) |
| Prepaid expenses and other assets | ($3.9M) | $7.1M | $4.2M | ($59.8M) |
| Accounts payable | ($21.7M) | $27.9M | ($5.1M) | ($1.6M) |
| Accrued expenses and other liabilities | $46.7M | $9.2M | $11.8M | ($15.0M) |
| Accrued compensation and employee benefits | $2.6M | ($23.4M) | ($4.0M) | $15.1M |
| Operating lease liabilities, net | ($11.7M) | ($15.5M) | ($13.6M) | ($3.3M) |
| Deferred revenue | ($22.4M) | $68.3M | $137.5M | $160.7M |
| Net cash provided by operating activities | $371.2M | $320.6M | $299.1M | ($10.0M) |
| Purchases of marketable securities | ($772.5M) | ($1.5B) | ($1.5B) | ($388.4M) |
| Maturities of marketable securities | $809.2M | $1.5B | $1.1B | $151.4M |
| Purchases of property and equipment | ($19.0M) | ($14.9M) | ($7.3M) | ($23.8M) |
| Payments related to business acquisitions, net of cash acquired | ($24.8M) | $0 | $0 | ($29.5M) |
| Other investing, net | ($15.4M) | $0 | $2.8M | $1.2M |
| Net cash used in investing activities | ($22.5M) | ($45.5M) | ($439.6M) | ($289.1M) |
| Repurchases of Class A common stock | ($329.1M) | ($390.8M) | ($102.6M) | — |
| Proceeds from exercise of stock options | $1.1M | $8.0M | $6.7M | $8.4M |
| Payments of tax withholdings on net settlement of equity awards | ($59.1M) | ($77.9M) | ($112.1M) | ($73.1M) |
| Proceeds from employee stock purchase plan contributions | $14.9M | $15.6M | $17.6M | $15.0M |
| Payments of deferred or contingent consideration related to business acquisitions | ($128.0K) | — | — | — |
| Net cash used in financing activities | ($372.4M) | ($450.5M) | ($196.9M) | ($60.7M) |
| Effect of exchange rate changes | $15.6M | ($7.0M) | ($2.6M) | ($6.8M) |
| Net decrease in cash, cash equivalents, and restricted cash | ($8.0M) | ($182.5M) | ($340.0M) | ($366.6M) |
| Cash, cash equivalents, and restricted cash at beginning of period | $879.6M | $1.1B | $1.4B | $1.8B |
| Cash, cash equivalents, and restricted cash at end of period | $871.6M | $879.6M | $1.1B | $1.4B |
| Cash paid for interest | $0 | $309.0K | $563.0K | $651.0K |
| Cash paid for income taxes, net | $9.8M | $16.7M | $10.8M | $21.0M |
| Deferred and contingent consideration recognized in connection with business acquisition | $9.8M | $0 | $0 | $11.4M |
| Tax withholdings on net settlement of restricted stock units, accrued but not yet paid | $4.7M | $4.7M | $3.4M | $2.2M |
| Property and equipment purchases included in accounts payable | $58.0K | $2.9M | $511.0K | $1.1M |
| Payable for repurchase of Class A common stock | $10.0M | — | — | — |
| Line item | Jul 31, 2026 · YTD | Apr 30, 2026 · Q1 | Oct 31, 2025 · YTD | Jul 31, 2025 · YTD |
|---|---|---|---|---|
| Net income (loss) | $58.6M | $22.5M | $177.9M | ($21.0M) |
| Depreciation and amortization | $16.5M | $7.5M | $12.0M | $7.5M |
| Amortization of deferred contract acquisition costs | $52.2M | $24.1M | $71.1M | $44.2M |
| Net accretion on marketable securities | ($933.0K) | ($701.0K) | ($9.0M) | ($7.0M) |
| Stock-based compensation expense | $98.3M | $53.3M | $225.8M | $154.4M |
| Charitable donation of Class A common stock | $3.0M | $3.0M | $4.2M | $4.2M |
| Non-cash operating lease expense | $8.7M | $4.3M | $12.9M | $8.7M |
| Provision for (benefit from) deferred income taxes | $27.9M | $11.4M | ($187.3M) | ($360.0K) |
| Change in fair value of contingent consideration | $3.3M | $2.4M | — | — |
| Other non-cash (credits) charges, net | ($6.4M) | ($829.0K) | $6.1M | $3.9M |
| Accounts receivable | $181.2M | $194.9M | $93.5M | $192.4M |
| Contract assets | ($40.3M) | ($14.0M) | ($37.1M) | ($23.5M) |
| Deferred contract acquisition costs | ($68.0M) | ($26.6M) | ($65.6M) | ($36.3M) |
| Prepaid expenses and other assets | ($12.2M) | ($12.9M) | ($10.4M) | ($21.2M) |
| Accounts payable | $6.9M | $9.4M | ($17.4M) | ($11.7M) |
| Accrued expenses and other liabilities | ($34.9M) | ($25.0M) | $36.0M | $37.8M |
| Accrued compensation and employee benefits | ($32.0M) | ($61.1M) | ($28.8M) | ($51.4M) |
| Operating lease liabilities, net | ($9.1M) | ($4.5M) | ($7.5M) | ($6.4M) |
| Deferred revenue | ($90.2M) | ($55.4M) | ($92.0M) | ($113.8M) |
| Net cash provided by operating activities | $162.6M | $131.9M | $188.9M | $160.6M |
| Purchases of marketable securities | ($309.4M) | ($155.0M) | ($507.2M) | ($300.1M) |
| Maturities of marketable securities | $329.2M | $189.6M | $585.1M | $257.1M |
| Purchases of property and equipment | ($4.1M) | ($2.7M) | ($16.0M) | ($12.8M) |
| Payments related to business acquisitions, net of cash acquired | ($149.4M) | ($149.4M) | ($24.8M) | ($24.8M) |
| Other investing, net | $5.1M | $4.6M | ($16.8M) | — |
| Net cash used in investing activities | ($128.6M) | ($112.8M) | $20.2M | ($80.6M) |
| Repurchases of Class A common stock | ($268.5M) | ($243.8M) | ($329.1M) | ($329.1M) |
| Proceeds from exercise of stock options | $691.0K | $349.0K | $967.0K | $523.0K |
| Payments of tax withholdings on settlement of equity awards | ($23.2M) | ($12.8M) | ($41.7M) | ($26.3M) |
| Proceeds from employee stock purchase plan contributions | $7.4M | $4.0M | $11.9M | $8.1M |
| Payments of deferred or contingent consideration related to business acquisitions | ($3.5M) | — | — | — |
| Net cash used in financing activities | ($287.1M) | ($252.2M) | ($358.0M) | ($346.8M) |
| Effect of exchange rate changes | ($9.6M) | ($4.8M) | $13.4M | $16.2M |
| Net decrease in cash, cash equivalents, and restricted cash | ($262.7M) | ($237.9M) | ($135.5M) | ($250.6M) |
| Cash, cash equivalents, and restricted cash - beginning of period | $871.6M | $871.6M | $879.6M | $879.6M |
| Cash, cash equivalents, and restricted cash - end of period | $608.9M | $633.7M | $744.1M | $629.1M |
| Cash paid for income taxes, net | $14.2M | $5.0M | $12.6M | $11.1M |
| Property and equipment purchases included in accounts payable | $60.0K | $60.0K | $60.0K | $62.0K |
| Contingent and deferred consideration recognized in connection with business acquisitions | $29.6M | $30.0M | $9.8M | $9.8M |
| Tax withholdings on net settlement of restricted stock units, accrued but not yet paid | $3.0M | $5.8M | $4.8M | $4.9M |
UiPath Inc. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.